0001567619-18-002329.txt : 20180907
0001567619-18-002329.hdr.sgml : 20180907
20180907193457
ACCESSION NUMBER: 0001567619-18-002329
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180905
FILED AS OF DATE: 20180907
DATE AS OF CHANGE: 20180907
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALVAREZ EDUARDO
CENTRAL INDEX KEY: 0001720126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34885
FILM NUMBER: 181061135
MAIL ADDRESS:
STREET 1: AMYRIS, INC.
STREET 2: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMYRIS, INC.
CENTRAL INDEX KEY: 0001365916
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 550856151
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-0761
MAIL ADDRESS:
STREET 1: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC
DATE OF NAME CHANGE: 20060613
4
1
doc1.xml
FORM 4
X0306
4
2018-09-05
0
0001365916
AMYRIS, INC.
AMRS
0001720126
ALVAREZ EDUARDO
C/O AMYRIS, INC.
5885 HOLLIS STREET, SUITE 100
EMERYVILLE
CA
94608
0
1
0
0
Chief Operating Officer
Common Stock
2018-09-05
4
P
0
11877
8.4471
A
331877
D
The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.42 to $8.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
/s/ Eduardo Alvarez by Stephen Dobson, Attorney-in-Fact
2018-09-07